Indivior Pharmaceuticals, Inc. (NasdaqGS: INDV)
Health Care · Pharmaceuticals · US
$35.70
-0.36% today · +48.4% 1Y
Indivior Pharmaceuticals, Inc. (NasdaqGS: INDV) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.23B and employs 833 people.
Over the last twelve months the share price has gained 48.4%, trading between 22.95 and 42.81.
Tweenvest scores Indivior Pharmaceuticals, Inc. across four factors: quality 53/100, value 46/100, growth 63/100. Its strongest factor is growth.
INDV price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.23B
- Revenue (TTM)
- $1.33B
- P/E
- 12.95
- EPS
- 2.77
- Dividend yield
- —
- Beta (5Y)
- 1.18
- 52-week high
- $42.81
- 52-week low
- $22.95
- Avg volume (3M)
- —
- Shares outstanding
- 118.01M
- Employees
- 833
- Next earnings
- —
About Indivior Pharmaceuticals, Inc.
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
- ISIN
- US45579U1097
- Founded
- 2014
- Listed since
- Dec 29, 2014
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Aspen Pharmacare Holdings LimitedJSE: APN | $4.25B | R158.26 | -1.09% |
| Edgewise Therapeutics, Inc.NasdaqGS: EWTX | $4.24B | $38.82 | -0.61% |
| Sam Chun Dang Pharm. Co., LtdKOSDAQ: A000250 | $4.24B | ₩243,500.00 | +17.63% |
| SK Biopharmaceuticals Co., Ltd.KOSE: A326030 | $4.23B | ₩72,700.00 | -4.09% |
| Yuhan CorporationKOSE: A000100 | $4.06B | ₩73,100.00 | -1.35% |
| J. B. Chemicals & Pharmaceuticals LimitedBSE: 506943 | $4.02B | Rs— | — |
| Zhejiang Huahai Pharmaceutical Co., Ltd.SHSE: 600521 | $3.88B | CN¥17.45 | +6.79% |
| Shijiazhuang Yiling Pharmaceutical Co., Ltd.SZSE: 002603 | $3.87B | CN¥15.53 | +1.17% |
Figures last refreshed Oct 11, 2026.